排列性谷氨酸酸盐代谢受损会诱导短暂的多巴胺增加和运动功能障碍
Mohd Yaseen Malik1, Fei Guo1, Aman Asif-Malik1
1Department of Pharmacology, University of Oxford, Oxford, UK.
Nature metabolism
|October 29, 2024
概括
亨廷顿病涉及多巴胺系统的变化. 减少特定神经元中的谷氨酸S转移酶omega-2 (GSTO2) 阻止了这些变化,并停止了小鼠的疾病症状.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 代谢途径 代谢途径
背景情况:
- 识别像亨廷顿病 (HD) 这样的神经退行性疾病的早期触发因素对于开发预防疗法至关重要.
- 超多巴胺和高动力是早期的疾病症状,可能与间接途径棘状投射神经元 (iSPNs) 的功能障碍有关.
- 驱动iSPN功能障碍的确切机制及其对疾病发病的贡献仍然不清楚.
研究的目的:
- 调查iSPN功能障碍在HD病变发生中的作用.
- 确定参与早期HD发育的分子途径.
- 探索预防HD进展的潜在治疗点.
主要方法:
- 在小鼠iSPN中Ntrk2/TrkB的遗传破坏.
- 在症状前阶段对iSPN的转录组分析.
- 在体内选择性减少Gsto2在iSPNs.
主要成果:
- 在iSPN中Ntrk2/TrkB的删除导致在超运动症状之前,条状多巴胺和中脑多巴胺基神经元的增加.
- 转录组分析显示了代谢途径的失调,包括高调的Gsto2.
- 选择性Gsto2降低iSPNs可以预防多巴胺功能障碍和高运动症状.
结论:
- 改变的iSPN BDNF-TrkB信号传递,谷甲酸代谢和超多巴胺基状态在HD中具有功能联系.
- 在维持多巴胺平衡方面,GSTO2起着至关重要的作用.
- 在iSPN中定位GSTO2可能为HD提供预防策略.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:24Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
01:15Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
01:30Attention-Deficit/Hyperactivity Disorder
46
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
46
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
261
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
261
01:23Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456